Component: (Network and Table)
Network
00500 - Statement - Consolidated Statements of Cash Flows
(http://www.ingredion.com/role/StatementConsolidatedStatementsOfCashFlows)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001046257 (http://www.sec.gov/CIK)
Consolidated Statements of Cash FlowsPeriod [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
Consolidated Statements of Cash Flows
 
 
 
Cash provided by operating activities:
 
 
 
Net income
496,000,000  
412,000,000  
363,000,000  
Non-cash charges to net income:
 
 
 
Depreciation and amortization
196,000,000  
194,000,000  
195,000,000  
Deferred income taxes
(5,000,000) 
(6,000,000) 
(11,000,000) 
Write-off of impaired assets
 
10,000,000  
33,000,000  
Gain on sale of plant
 
(10,000,000) 
 
Charge for fair value mark-up of acquired inventory
 
10,000,000  
 
Other
101,000,000  
96,000,000  
68,000,000  
Changes in working capital:
 
 
 
Accounts receivable and prepaid expenses
(131,000,000) 
(29,000,000) 
(15,000,000) 
Inventories
(19,000,000) 
9,000,000  
(6,000,000) 
Accounts payable and accrued liabilities
127,000,000  
30,000,000  
66,000,000  
Margin accounts
15,000,000  
(34,000,000) 
39,000,000  
Other
(9,000,000) 
4,000,000  
(1,000,000) 
Cash provided by operating activities
771,000,000  
 
686,000,000  
 
731,000,000  
 
Cash used for investing activities:
 
 
 
Payments for acquisitions, net of cash acquired of $4, $16 and $-, respectively
(407,000,000) 
(434,000,000) 
 
Capital expenditures
(284,000,000) 
(280,000,000) 
(276,000,000) 
Investment in non-consolidated affiliate
(2,000,000) 
  
Short-term investments
1,000,000  
27,000,000  
(34,000,000) 
Proceeds from disposal of plants and properties
3,000,000  
38,000,000  
5,000,000  
Proceeds from sale of investment
  
11,000,000  
Cash used for investing activities
(689,000,000) 
 
(649,000,000) 
 
(294,000,000) 
 
Cash provided by (used for) financing activities:
 
 
 
Proceeds from borrowings
1,000,000,000  
1,388,000,000  
231,000,000  
Payments on debt
(874,000,000) 
(1,366,000,000) 
(213,000,000) 
Debt issuance costs
(6,000,000) 
  
Repurchase of common stock
(8,000,000) 
(41,000,000) 
(304,000,000) 
Issuance of common stock
29,000,000  
21,000,000  
20,000,000  
Dividends paid (including to non-controlling interests)
(141,000,000) 
(126,000,000) 
(128,000,000) 
Excess tax benefit on share-based compensation
 
8,000,000  
6,000,000  
Cash used for financing activities
 
 
(116,000,000) 
 
(388,000,000) 
 
Effect of foreign exchange rate changes on cash
(4,000,000) 
(67,000,000) 
(43,000,000) 
Increase (decrease) in cash and cash equivalents
78,000,000  
 
(146,000,000) 
 
6,000,000  
 
Cash and cash equivalents, beginning of period
434,000,000  
580,000,000  
574,000,000  
Cash and cash equivalents, end of period
512,000,000  
 
434,000,000  
 
580,000,000